1335496-06-4Relevant academic research and scientific papers
AROMATIC HETEROCYCLIC COMPOUND WITH KINASE INHIBITORY ACTIVITY
-
Paragraph 0120; 0127-0128, (2021/07/29)
Provided are a JAK kinase inhibitor, preparation and use thereof. In particular, provided is a compound of Formula I, wherein each group is as described in the specification. The compound has an excellent JAK inhibitory activity, and therefore can be used to prepare pharmaceutical compositions for the treatment of cancer and other diseases related to JAK activity.
A XINAFOATE SALT OF A JAK INHIBITING COMPOUND
-
Page/Page column 27-28, (2020/02/22)
The present disclosure relates to salts of compounds of Formula (I) prepared as a xinafoate (1-hydroxy-2-naphthoate) salt (Formula (Ia)), pharmaceutically acceptable compositions comprising same and methods of using the same.
JAK1 SELECTIVE INHIBITORS
-
Page/Page column 38, (2018/08/12)
Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.
INDAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
-
, (2011/10/13)
Disclosed are compounds having the formula: or a salt thereof, wherein A, n, R1, R1A, and R2 are as defined herein, and methods of making and using the same.
